Cream for frontal fibrosing alopecia
Treatments studied
Part of Skin clinical trials.
This trial tests a cream called delgocitinib to see if it can reduce redness and scaling in people with frontal fibrosing alopecia, a type of hair loss. It may help improve your symptoms if other treatments haven't worked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with frontal fibrosing alopecia by a doctor.
- Your affected area shows moderate to severe redness or scaling.
- You are willing to keep the same hair style and hair products, and avoid weaves or extensions during the trial.
- You have not used certain hair-growth supplements or treatments in the past 4 weeks.
- You have not had a prior bad response to other JAK inhibitor creams or pills for this condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether laser therapy can help treat small bumps (papules) that appear on the face in people with frontal fibrosing alopecia, a type of hair loss. If you have these bumps and are generally healthy, you may be able to join.
This study tests an oral medication called deucravacitinib for people with scarring hair loss (frontal fibrosing alopecia or central centrifugal cicatricial alopecia). It aims to see if the drug can reduce inflammation and stop or slow hair loss.
This trial compares two common medicines, hydroxychloroquine and methotrexate, to see which works better for treating frontal fibrosing alopecia (a type of hair loss). You and your doctor can choose which treatment you prefer.
This study tests an oral medication called delgocitinib, which targets certain enzymes linked to inflammation, in people with central centrifugal cicatricial alopecia (CCCA) or lichen planopilaris (LPP). It aims to see if the drug is safe and if it changes biomarkers (biological signals) related to these conditions.
This trial tests a cream applied to the skin that may help control early-stage mycosis fungoides, a type of skin lymphoma. It aims to see if the cream can reduce symptoms and slow disease progression without the need for stronger treatments.
This trial tests a new treatment (DA-001) to reduce hair shedding and help hair grow back in people with telogen effluvium—a temporary hair loss condition. The treatment is applied directly to the scalp, and participants will be followed to see how well it works.
Hear when a new Frontal Fibrosing Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.